Novel antibodies that bind to CD3 and lilrb4, and uses thereof
MX2026006963APending Publication Date: 2026-10-02ANTENGENE BIOLOGICS LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MX2026006963
- Authority / Receiving Office
- MX · MX
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-05
- Filing Date
- 2026-06-05
- Publication Date
- 2026-10-02
Abstract
Provided herein are multi-specific, especially bispecific or tri-specific, antibodies or antigen-binding fragments thereof that bind to CD3 and LILRB4, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same and the uses thereof.
Need to check novelty before this filing date? Find Prior Art